Reduced caspase-2 expression has been reported in some cases of Burkitt lymphoma, mantle cell lymphoma (MCL), chronic lymphocytic leukemia (CLL), and acute myeloid leukemia (AML)86,87. Here, CASP2 is linked to acute myeloid leukemia.